Zoetis Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-12-31 was 12.84K shares.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 111.37K shares, a 64.73% decline from fiscal 2024.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 315.74K shares, a 54.63% decline from fiscal 2023.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 695.99K shares, a 164.46% increase from fiscal 2022.
- Zoetis Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 263.17K shares, a 61.35% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 111.37K shares 10-K · filed 2026-02-12 | |
| 2024-12-31 | 315.74K shares 10-K · filed 2025-02-13 | |
| 2023-12-31 | 695.99K shares 10-K · filed 2024-02-13 | |
| 2022-12-31 | 263.17K shares 10-K · filed 2023-02-14 | |
| 2021-12-31 | 680.97K shares 10-K · filed 2022-02-15 | |
| 2020-12-31 | 1.20M shares 10-K · filed 2021-02-16 | |
| 2019-12-31 | 1.12M shares 10-K · filed 2020-02-13 | |
| 2018-12-31 | 1.19M shares 10-K · filed 2019-02-14 | |
| 2017-12-31 | 1.15M shares 10-K · filed 2018-02-15 | |
| 2016-12-31 | 1.26M shares 10-K · filed 2017-02-16 | |
| 2015-12-31 | 293.36K shares 10-K · filed 2016-02-24 | |
| 2014-12-31 | 58.54K shares 10-K · filed 2015-02-27 | |
| 2013-12-31 | 12.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | 6.42K shares 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |